These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Gene Therapy in Retinal Dystrophies. Ziccardi L; Cordeddu V; Gaddini L; Matteucci A; Parravano M; Malchiodi-Albedi F; Varano M Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739639 [TBL] [Abstract][Full Text] [Related]
31. An early history of gene transfer and therapy. Wolff JA; Lederberg J Hum Gene Ther; 1994 Apr; 5(4):469-80. PubMed ID: 8049304 [TBL] [Abstract][Full Text] [Related]
32. Light-driven cone arrestin translocation in cones of postnatal guanylate cyclase-1 knockout mouse retina treated with AAV-GC1. Haire SE; Pang J; Boye SL; Sokal I; Craft CM; Palczewski K; Hauswirth WW; Semple-Rowland SL Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3745-53. PubMed ID: 16936082 [TBL] [Abstract][Full Text] [Related]
33. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728 [TBL] [Abstract][Full Text] [Related]
34. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis. Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444 [TBL] [Abstract][Full Text] [Related]
35. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115 [TBL] [Abstract][Full Text] [Related]
36. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Dalkara D; Byrne LC; Klimczak RR; Visel M; Yin L; Merigan WH; Flannery JG; Schaffer DV Sci Transl Med; 2013 Jun; 5(189):189ra76. PubMed ID: 23761039 [TBL] [Abstract][Full Text] [Related]
37. The growing clinical impact of gene therapy. Nienhuis A Mol Ther; 2008 Jun; 16(6):995-6. PubMed ID: 18500234 [No Abstract] [Full Text] [Related]
38. Evolution of adenoviruses as gene therapy vectors. Roy-Chowdhury J; Horwitz MS Mol Ther; 2002 Apr; 5(4):340-4. PubMed ID: 11945059 [No Abstract] [Full Text] [Related]
39. AAV-mediated gene therapy for retinal disorders: from mouse to man. Buch PK; Bainbridge JW; Ali RR Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417 [TBL] [Abstract][Full Text] [Related]